Adherence to disease-modifying therapies in patients with multiple sclerosis
Aleksandra Kołtuniuk, Joanna Rosińczuk Department of Nervous System Diseases, Faculty of Health Sciences, Wroclaw Medical University, Wroclaw, Poland Background: Multiple sclerosis (MS) is a chronic, inflammatory progressive demyelinating disease of the central nervous system. MS is one o...
Main Authors: | Kołtuniuk A, Rosińczuk J |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2018-08-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/adherence-to-disease-modifying-therapies-in-patients-with-multiple-scl-peer-reviewed-article-PPA |
Similar Items
-
Adherence to disease modifying therapies in patients with multiple sclerosis
by: D. Pileckė, et al.
Published: (2019-06-01) -
Ways to improve adherence to long-term injection therapy in multiple sclerosis using the example of pegylated interferon-β1a (sampeginterferon β-1a)
by: A. N. Boyko
Published: (2022-08-01) -
Treatment satisfaction with disease-modifying therapy is the only predictor of Adherence among multiple sclerosis patients from Upper Egypt
by: Eman M. Khedr, et al.
Published: (2024-03-01) -
Treatment patterns and persistence on disease modifying therapies for multiple sclerosis and its associated factors
by: Simón Cárdenas-Robledo, et al.
Published: (2024-04-01) -
The Effect of Implementing an Educational Program on Adherence to Treatment and Self-Compassion of Patients with Multiple Sclerosis
by: Hanie Dahmardeh, et al.
Published: (2024-11-01)